Skip to content

Effects of rTMS on Balance Performance and Functional Mobility in Parkinson's Disease

Effects of Repetitive Transcranial Magnetic Stimulation on Balance Performance and Functional Mobility in People With Parkinson's Disease : A Double-Blind Randomized Crossover Pilot Study

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07195773
Enrollment
21
Registered
2025-09-29
Start date
2024-12-16
Completion date
2025-11-19
Last updated
2026-02-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Balance, Excitability, Motor Cortex, Motor Skills Disorders, Parkinson Disease

Brief summary

This study aimed to investigate the effects of rTMS on balance performance and functional mobility in people with PD. Additionally, it further examines the effects of single-session low-frequency and high-frequency repetitive transcranial magnetic stimulation on balance performance and functional mobility.

Interventions

DEVICErTMS

Participants will receive different stimulation approaches in sequences: high-frequency rTMS, low-frequency rTMS, and sham rTMS. They will be randomly assigned to three groups with different stimulation sequences. After each single stimulation, balance performance, functional mobility, and motor symptoms will be measured. In this study, eighteen PD patients with Hoehn and Yahr stage 1 to 3 will be recruited.

Sponsors

Chung Shan Medical University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
40 Years to 85 Years
Healthy volunteers
No

Inclusion criteria

1. Patients with primary Parkinson's disease 2. Age: 40-85 years 3. Hoehn and Yahr scale (H\&Y scale) : I-III 4. Appropriate prescribed medication, and regular intake for more than 2 weeks 5. Can walk more than 10m with or without the use of assistive devices

Exclusion criteria

1. Any other neurological presentation (Excluding PD) 2. Any neurological surgery that would affect participation in this experiment 3. Orthopedic pathology and Cardiovascular issues 4. MMSE≦24 5. Exercise used for treatment in the last three months 6. Contraindications for transcranial magnetic stimulation (Presence of metal implants in the head and neck, a pacemaker in the chest, personal or family history of epilepsy, recent brain injury, currently taking antidepressant medication.)

Design outcomes

Primary

MeasureTime frameDescription
Dynamic balanceFRT will be assessed before and immediately after each intervention. Each intervention is separated by a 2-week washout period. All assessments occur within an 4-week period.Functional Reach Test
Functional mobilityTUG will be assessed before and immediately after each intervention. Each intervention is separated by a 2-week washout period. All assessments occur within an 4-week period.Timed Up and Go test
Motor functionUPDRS-III will be assessed before and immediately after each intervention. Each intervention is separated by a 2-week washout period. All assessments occur within an 4-week period.UPDRS-III

Countries

Taiwan

Contacts

STUDY_CHAIRLIU HSIN-HSUAN, PhD

Assistant Professor

PRINCIPAL_INVESTIGATORHONG SONG-PING, BSc

student

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 28, 2026